{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:24Z","timestamp":1790802684081,"version":"4.1.0"},"reference-count":29,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.nephro.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T03:50:13Z","timestamp":1364529013000},"page":"154-159","source":"Crossref","is-referenced-by-count":4,"title":["Quels marqueurs osseux chez les patients h\u00e9modialys\u00e9s\u00a0: phosphatases alcalines osseuses ou \u00df-CrossLaps\u00a0?"],"prefix":"10.1684","volume":"9","author":[{"given":"Guillaume","family":"Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Souberbielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Granjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Lorriaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Hurot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Deleaval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"issue":"Suppl.\u00a0113","key":"10.1016\/j.nephro.2013.02.006_bib0005","first-page":"S1","article-title":"Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone disorder (CKD-MBD)","volume":"76","author":"KDIGO C-M, Work Group KDIGO","year":"2009","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.nephro.2013.02.006_bib0010","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.nephro.2013.02.006_bib0015","doi-asserted-by":"crossref","first-page":"c132","DOI":"10.1159\/000334424","article-title":"Increased levels of serum parathyroid hormone and fibroblast growth factor-23\u00a0are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients","volume":"120","author":"Jean","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"10.1016\/j.nephro.2013.02.006_bib0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Qi","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.nephro.2013.02.006_bib0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clinbiochem.2012.01.018","article-title":"Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease","volume":"45","author":"Jean","year":"2012","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.nephro.2013.02.006_bib0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00198-004-1712-4","article-title":"Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients","volume":"16","author":"Okuno","year":"2005","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.nephro.2013.02.006_bib0035","first-page":"c112","article-title":"Evaluation of serum beta-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients","volume":"98","author":"Reichel","year":"2004","journal-title":"Nephron"},{"issue":"5","key":"10.1016\/j.nephro.2013.02.006_bib0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.bone.2011.01.016","article-title":"Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)","volume":"48","author":"Manghat","year":"2011","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.nephro.2013.02.006_bib0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1542-4758.2009.00430.x","article-title":"Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients","volume":"14","author":"Park","year":"2010","journal-title":"Hemodialys Int"},{"issue":"10","key":"10.1016\/j.nephro.2013.02.006_bib0050","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.lfs.2005.02.007","article-title":"Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH","volume":"77","author":"Ueda","year":"2005","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.nephro.2013.02.006_bib0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.nephro.2013.02.006_bib0060","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.nephro.2013.02.006_bib0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.nephro.2013.02.006_bib0070","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.07020711","article-title":"Racial differences in markers of mineral metabolism in advanced chronic kidney disease","volume":"7","author":"Jovanovich","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.nephro.2013.02.006_bib0075","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/oxfordjournals.ndt.a027356","article-title":"Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429\u00a0iliac crest biopsies","volume":"11","author":"Ballanti","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.nephro.2013.02.006_bib0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1744-9987.2006.00375.x","article-title":"Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism","volume":"10","author":"Kazama","year":"2006","journal-title":"Ther Apher Dial"},{"issue":"1","key":"10.1016\/j.nephro.2013.02.006_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CNP68063","article-title":"12months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers","volume":"68","author":"Jean","year":"2007","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1016\/j.nephro.2013.02.006_bib0090","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/ndt\/gfh214","article-title":"Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study","volume":"19","author":"Sanchez","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4\u00a0Suppl 3","key":"10.1016\/j.nephro.2013.02.006_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"Bone metabolism and disease in chronic kidney disease","volume":"42","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.nephro.2013.02.006_bib0100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1210\/jcem-60-6-1253","article-title":"Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation","volume":"60","author":"Epstein","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.nephro.2013.02.006_bib0105","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2215\/CJN.06091108","article-title":"Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients","volume":"4","author":"Shantouf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.nephro.2013.02.006_bib0110","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2215\/CJN.01560309","article-title":"Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease","volume":"4","author":"Beddhu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.nephro.2013.02.006_bib0115","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Urena","year":"1999","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.nephro.2013.02.006_bib0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.2012.77","article-title":"Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients","volume":"82","author":"Sardiwal","year":"2012","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.nephro.2013.02.006_bib0125","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/oxfordjournals.ndt.a027457","article-title":"Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients","volume":"11","author":"Couttenye","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.nephro.2013.02.006_bib0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.nephro.2013.02.006_bib0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ki.2010.356","article-title":"Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease","volume":"79","author":"Damera","year":"2011","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.nephro.2013.02.006_bib0140","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.nephro.2013.02.006_bib0145","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00467-006-0378-x","article-title":"Effect of haemodialysis on markers of bone turnover in children","volume":"22","author":"Waller","year":"2007","journal-title":"Pediatr Nephrol"}],"container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725513000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725513000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2013.02.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:42:05Z","timestamp":1741185725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725513000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1769725513000497"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2013.02.006","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}